5 completed. 5 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 5 |
| Phase 2 | 3 | Completed 3 |
Follow Drug Addiction: new trials by email Literature Review of Drug Addiction trials Research Report on Drug Addiction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Medication Treatment for Opioid Use Disorder in Expectant Mothers Buprenorphine Injection, Buprenorphine Sublingual Product - Opioid-Related Disorders, Drug Addiction | Phase 3 | Completed | T. John Winhusen, PhD | 140 | 2020-07-21 | 2026-06-04 |
| The Role of Sleep in the Treatment of Cannabis Use Disorders Zolpidem extended-release, MET/CBT - Drug Addiction | Phase 2 / Phase 3 | Completed | Johns Hopkins University | 127 | 2012-09-01 | 2019-05-22 |
| Comparing Acute and Continuous Drug Abuse Treatment: A Randomized Clinical Trial Treatment as Usual (TAU), TAU + Long-Term Recovery Management - Drug Addiction | Phase 3 | Completed | Wright State University | 204 | 2009-11-05 | 2022-03-09 |
| Treating the Partners of Drug Using Pregnant Women: Stage II Enhanced care, control - Drug Addiction | Phase 2 / Phase 3 | Completed | Johns Hopkins University | 158 | 2005-10-01 | 2013-03-05 |
| Recovery Housing For Drug Dependent Pregnant Women RBT, usual care - Drug Addiction | Phase 2 / Phase 3 | Completed | Johns Hopkins University | 128 | 2004-11-01 | 2013-03-05 |
Substance-Related Disorders (5) · Neonatal Abstinence Syndrome (2) · Marijuana Abuse (1) · Opioid-Related Disorders (1) · Recurrence (1) · Sleep Initiation and Maintenance Disorders (1)
Chemically-Induced Disorders (5) · Mental Disorders (5) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Infant, Newborn, Diseases (2) · Disease Attributes (1) · Dyssomnias (1) · Narcotic-Related Disorders (1) · Nervous System Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Sleep Disorders, Intrinsic (1) · Sleep Wake Disorders (1)
Buprenorphine (1) · Buprenorphine, Naloxone Drug Combination (1) · Therapeutics (1) · Zolpidem (1)
Johns Hopkins University (3) · T. John Winhusen, PhD (1) · Wright State University (1)
United States (5)
Brenda M Booth, Ph.D. (1) · Gregory Brigham, Ph.D. (1) · Hendree E Jones, PhD (1) · Hendree Jones, PhD (1) · Robert G Carlson, Ph.D. (1) · Russel Falck, MA (1) · Ryan Vandrey, PhD (1) · T. John Winhusen, PhD (1)
PMID 21410418, PMID 22221277, PMID 23157895, PMID 28782982, PMID 37023858, PMID 39105509, PMID 40643178, PMID 41015387, PMID 41429292, PMID 41837971
1RC1DA028467-01 (1), R01DA013496 (1), R01DA014979 (1), U01DA031784 (1), UG1DA013732 (1)